pharma · Parkinson's Disease
Lundbeck Romania
Lundbeck Australia Pty Ltd
Lundbeck Australia Pty is a pharma organization headquartered in AU. Primary therapeutic focus areas include Parkinson's Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to t
AU HQ
1994 Founded
3 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- AU
- Founded
- 1994
- Employees
- 3
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Melperone HCl
Phase 2 · small molecule · Parkinson's Disease
Melperone HCl for Parkinson's Disease is a Phase 2 program (small_molecule) at Lundbeck Australia Pty Ltd with 1 ClinicalTrials.gov record(s).
Internal code 13104A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Lundbeck Australia Pty Ltd
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Parkinson's Disease
- Status
- completed
- Trials
- 1